1. Mu, Mingchao, Zhang, Qin, Li, Jing, Sun, Xuejun, Yu, Junhui. 2023. USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A. In Cell death and differentiation, 30, 2393-2407. doi:10.1038/s41418-023-01228-8. https://pubmed.ncbi.nlm.nih.gov/37816999/
2. Chen, Jin, Wu, Zhongqiu, Deng, Wenyi, Chen, Changguo, Li, Wenting. 2023. USP51 promotes non-small cell lung carcinoma cell stemness by deubiquitinating TWIST1. In Journal of translational medicine, 21, 453. doi:10.1186/s12967-023-04304-2. https://pubmed.ncbi.nlm.nih.gov/37422632/
3. Li, Jianjun, Xiao, Xuechun, Wang, Hang, Zhang, Zhen, Yang, Shuang. 2022. CDK4/6-USP51 axis regulates lung adenocarcinoma metastasis through ZEB1. In Cancer gene therapy, 29, 1181-1192. doi:10.1038/s41417-021-00420-7. https://pubmed.ncbi.nlm.nih.gov/35058607/
4. Liu, Yuan-Jie, Zeng, Shu-Hong, Zhang, Wei, Liu, Shen-Lin, Zou, Xi. 2023. USP51/ZEB1/ACTA2 axis promotes mesenchymal phenotype in gastric cancer and is associated with low cohesion characteristics. In Pharmacological research, 188, 106644. doi:10.1016/j.phrs.2022.106644. https://pubmed.ncbi.nlm.nih.gov/36603607/
5. Wang, Zhiquan, Zhang, Honglian, Liu, Ji, You, Zhongsheng, Zhang, Zhiguo. . USP51 deubiquitylates H2AK13,15ub and regulates DNA damage response. In Genes & development, 30, 946-59. doi:10.1101/gad.271841.115. https://pubmed.ncbi.nlm.nih.gov/27083998/